About company

OCRA is a pharmaceutical start-up from Oxford (UK) that aims to extend the life expectancy of cancer patients by identifying molecules that synergistically improve the effectiveness of current standard-of-care anti-cancer treatments, including radiation therapy, chemotherapy, and immunotherapy.

Unknown
Unknown
Unknown
Not verified company